Title |
Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF)
|
---|---|
Published in |
Trials, May 2013
|
DOI | 10.1186/1745-6215-14-138 |
Pubmed ID | |
Authors |
Ya Zhu Hou, Shuai Wang, Zhi Qiang Zhao, Xian Liang Wang, Bin Li, Shan Bin Soh, Jing Yuan Mao |
Abstract |
Heart failure (HF) is associated with decreased quality of life, high re-admission rate and poor prognosis. In particular, ischemic heart failure (IHF) has a worse prognosis than nonischemic HF. The use of traditional Chinese medicine (TCM) alongside Western medicine to treat HF has developed into an integrative treatment model in China. There have been small clinical trials and experimental studies to demonstrate the efficacy of TCM for treating HF; however, there is still a lack of high-quality trials. Qishen Yiqi dripping pills (QSYQ), a TCM drug, have been commonly used alongside standardized Western medicine to treat IHF. This paper describes the protocol for the clinical assessment of QSYQ in IHF patients. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 3 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
United States | 1 | <1% |
Unknown | 115 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 18 | 15% |
Researcher | 13 | 11% |
Student > Bachelor | 12 | 10% |
Student > Ph. D. Student | 12 | 10% |
Other | 6 | 5% |
Other | 14 | 12% |
Unknown | 42 | 36% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 30 | 26% |
Nursing and Health Professions | 15 | 13% |
Biochemistry, Genetics and Molecular Biology | 6 | 5% |
Sports and Recreations | 4 | 3% |
Psychology | 3 | 3% |
Other | 11 | 9% |
Unknown | 48 | 41% |